Novartis Investigative Site

Negrar 37024

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Breast Cancer

Studies at this site

• Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast Cancer — Completed